Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Action modulators |
Mechanism PTCRA modulators(pre T cell antigen receptor alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| T-cell Acute Lymphoblastic Leukemia/Lymphoma | Preclinical | United States | 21 Jul 2022 |






